Nimbus exposes complete ACLY structure, discovers allosteric inhibitory sites

Nimbus is spinning out a subsidiary to develop ACLY inhibitors targeting a new allosteric site on the enzyme that it discovered in collaboration with Schrödinger and Columbia University.

BioCentury identified lipid biosynthesis regulator

Read the full 327 word article

How to gain access

Continue reading with a
two-week free trial.